Elevated liver tests in a person who drinks – what they may mean
A blood test result showing elevated liver enzymes in a person who drinks alcohol is one of the most common reasons for referral to a hepatologist. However, interpreting these results is complex and requires consideration of many factors – not just the numbers themselves. Which enzymes are elevated, by how much, how they relate to each other, what other parameters accompany the elevation and what the clinical presentation of the patient is – all of this together determines what the results actually mean and what needs to be done next.
Liver enzymes – what they measure and what they do not
The commonly used term “liver function tests” is in fact imprecise and can be misleading. AST, ALT and GGT do not measure liver function – they measure hepatocyte damage or enzymatic induction. True assessment of liver function is based on other parameters: albumin, INR, bilirubin and possibly challenge tests.
This distinction has crucial clinical significance: the liver may have significantly elevated enzymes with preserved good function (e.g. early alcoholic steatosis), but it may also have normal or moderately elevated enzymes with seriously impaired function (e.g. burnt-out cirrhosis with minimal active necrosis). Hepatological assessment must address both aspects.
GGT – the most sensitive marker of alcohol misuse
Gamma-glutamyltransferase (GGT) is an enzyme involved in glutathione metabolism and amino acid transfer across cell membranes. Its serum activity rises with liver damage or enzymatic induction in the liver, bile ducts and kidneys.
GGT is the most sensitive laboratory marker of alcohol misuse – it rises in 70-80% of chronic drinkers, often before any clinical symptoms or elevation of other enzymes appear. The mechanism is twofold: direct damage to hepatocytes by alcohol and acetaldehyde, and enzymatic induction – alcohol activates GGT gene expression through the microsomal ethanol oxidation pathway.
Important limitation: GGT is non-specific. It rises with many medications (phenytoin, phenobarbital, rifampicin), thyroid disorders, obesity and pancreatic disease. Isolated GGT elevation in a person suspected of having an alcohol problem is a strong signal, but not a verdict – it always requires assessment in the context of the overall clinical picture.
After stopping drinking, GGT normalises within 4-8 weeks – making it a useful tool for monitoring abstinence. Failure to normalise after 8 weeks suggests continued drinking, other liver disease or baseline high enzyme activity.
AST and ALT – enzymes of hepatocyte damage
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) are cytosolic enzymes released into the blood when hepatocytes are damaged or undergo necrosis. ALT is more specific for the liver – AST also occurs in cardiac muscle, skeletal muscles and erythrocytes, which can complicate interpretation.
In alcoholic liver disease, AST and ALT values rarely exceed 300-400 IU/L – even in severe alcoholic hepatitis. This is an important observation: very high aminotransferases (above 1000 IU/L) in alcoholic disease suggest a co-existing other cause – acute infection with a hepatotropic virus, liver ischaemia or toxic drug damage.
The De Ritis ratio – AST/ALT
The AST/ALT ratio, described by Italian hepatologist Fernando De Ritis in 1957, remains one of the oldest and still useful diagnostic tools in hepatology. Its value stems from the pathophysiological mechanism specific to alcoholic liver disease.
In people misusing alcohol, deficiency of pyridoxal-5-phosphate (active form of vitamin B6) occurs – a cofactor essential for ALT activity. Alcohol impairs vitamin B6 metabolism, selectively reducing ALT activity while preserving or less reducing AST activity. The result is an AST/ALT ratio above 2 – characteristic of alcoholic liver damage and rarely observed in other liver diseases.
Bilirubin – when jaundice becomes an alarm signal
Total bilirubin above 1.2 mg/dl indicates disturbances in its metabolism. In alcoholic liver disease, elevated bilirubin usually means impaired liver function or cholestasis.
Bilirubin above 3 mg/dl is clinically visible as jaundice. Bilirubin above 12-15 mg/dl with co-existing elevated INR and creatinine (the MELD score triad) indicates severe functional impairment and is associated with high short-term mortality in alcoholic hepatitis.
Patterns of enzyme elevation – what they say about the degree of damage
Other causes of enzyme elevation in a drinker – diagnostic pitfalls
Not every enzyme elevation in a person who drinks alcohol is caused directly by alcohol. Viral hepatitis – particularly HCV – is significantly more common among people with alcohol dependence than in the general population. Alcohol and HCV act synergistically, accelerating progression to cirrhosis 5-10 fold compared to either alone. Every person with alcoholic liver disease should be tested for HBsAg, anti-HCV and anti-HBc.
Non-alcoholic fatty liver disease (NAFLD/NASH) can coexist with alcoholic disease – particularly in patients with obesity, diabetes and metabolic syndrome. Hepatotoxic drugs – paracetamol (especially combined with alcohol), methotrexate, isoniazid – can cause liver damage amplified by concurrent alcohol use.
When results require urgent hepatological consultation
Routine GGT elevation in a drinker without symptoms and with normal liver synthetic function does not require immediate hepatological consultation – but it does require abstinence, monitoring and patient education. However, a number of situations require faster action.
Frequently asked questions
Which liver tests are elevated with alcohol misuse?
Most commonly GGT – the most sensitive marker. AST and ALT reflect cell damage. AST/ALT ratio above 2 is characteristic of alcoholic liver disease. Elevated bilirubin and low albumin indicate synthetic function impairment – a more serious signal.
Do elevated liver tests always mean serious disease?
Not always – mild elevation up to 3 times the norm without symptoms may indicate reversible steatosis. Elevation above 5-10 times, especially with rising bilirubin and INR, requires urgent hepatological evaluation.
How quickly do liver tests normalise after stopping drinking?
GGT within 4-8 weeks. ALT and AST within 2-4 weeks. Failure to normalise after 8-12 weeks of abstinence is an indication for deeper investigation.
What is the AST/ALT ratio and why does it matter?
The De Ritis ratio – above 2 is characteristic of alcoholic liver disease due to vitamin B6 deficiency selectively impairing ALT. Values below 1 are more typical of viral hepatitis.
References
- Cohen JA, Kaplan MM. The SGOT/SGPT ratio – an indicator of alcoholic liver disease. Dig Dis Sci. 1979;24(11):835-838.
- Nyblom H, Berggren U, Balldin J, Olsson R. High AST/ALT ratio may indicate advanced alcoholic liver disease rather than heavy drinking. Alcohol Alcohol. 2004;39(4):336-339.
- European Association for the Study of the Liver (EASL). EASL Clinical Practice Guidelines: Alcohol-related liver disease. J Hepatol. 2018;69(1):154-181.
- Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance. Hepatology. 2020;71(1):306-333.
- Teschke R. Alcoholic liver disease: alcohol metabolism, cascade of molecular mechanisms. Biomedicines. 2018;6(4):106.
- Sherman KE. Alanine aminotransferase in clinical practice. Arch Intern Med. 1991;151(2):260-265.
CLINICAL INQUIRY
The form is intended for submitting a clinical inquiry. Messages are delivered directly to the team responsible for treatment coordination.
Related Treatment Areas
Clinical Contact
Contact with the center is intended for providing information regarding inpatient treatment and coordinating next steps in a confidential and non-binding manner.
Scope of Treatment and Informational Nature of Content
Inpatient treatment provided at Zeus Detox & Rehab is clinical in nature and focuses on medical stabilization, psychiatric assessment, and therapeutic intervention appropriate to the diagnosed condition and stage of the disorder. The scope and structure of treatment are determined individually by the clinical team based on the patient’s current health status and applicable medical standards.
The information presented on this website is for educational and informational purposes only. It does not constitute medical advice and should not be used as a basis for self-directed treatment decisions. Addiction and mental health treatment require individual medical qualification and clinical assessment.
